Biotech | February 17, 2022
Pebble engages MD Anderson to evaluate multi-cannabinoid formulations in ovarian cancer
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
Despite advances over the past 20 years, ovarian cancer treatment requires better standard of care
The supplemental adolescent approval enhances Solosec’s strong position as the first and only single-dose oral prescription antimicrobial agent approved for the treatment of both trichomoniasis and BV
The capex during the last nine months has been around Rs 110 crores which is all funded through internal accruals
TRIS AMINO HCl is widely used as a diagnostic reagent and as a downstream processing buffer in the purification of commercial biopharmaceuticals
BDR Pharmaceuticals is a home-grown company with operations in India and overseas. It’s known for its formulations portfolio and has a presence in specialty medicines. The company has ambitious plans as it has ramped up capacity and looking to foray into regulated markets. Raheel Shah, Director, BDR Group of Companies shares his insights in an interview with Thomas C Thottathil, Editor, Indian Pharma Post
Launches a host of innovative products & solutions across the entire flexible packaging value chain in October - December 2021
She holds a Masters degree in Genetics along with a Ph.D. in Biochemistry
Vonage Communications APIs allow developers to easily enhance and build intelligent, intuitive customer experiences directly into their existing applications and devices
Monitoring results demonstrated a good safety profile of the combination. No serious adverse events related to vaccination were registered
The first patient in India treated at Jaslok Hospital and Research Centre, Mumbai Includes the world’s smallest implantable spinal cord stimulator
Subscribe To Our Newsletter & Stay Updated
